Cancer Health Treatment Update Most People With Cancer Respond Well to COVID-19 Vaccines Most cancer patients with solid tumors have good antibody responses after receiving COVID-19 vacines, but the response rate is lower for those with blood cancers. Survival Benefits of Immunotherapy Combination Persist for More Than Six Years in Patients With Advanced Melanoma More people treated with Opdivo plus Yervoy reached the 6.5-year survival mark than those treated with either drug alone. Black Women Are Six Times More Likely to Experience Breast Cancer Metastasis Study finds Black women had a worse prognosis following a breast cancer diagnosis. News from the ASCO Annual Meeting The American Society of Clinical Oncology conference went virtual again this year, but there was still plenty of practice-changing news. Advertisement Cancer Patients Still Face COVID-19 Pandemic-Related Health Care Delays One in three report that the COVID-19 pandemic has affected their access to care more than a year after it began. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Summer 2021 Check out our latest print edition! Newsfeed Women Drinking More to Cope, Alarming Researchers Cancer Patients Still Face COVID-19 Pandemic-Related Health Care Delays World Blood Donor Day 2021: Give Blood and Keep the World Beating Discussing End-of-Life Care May Boost Hope for People With Advanced Cancer Blog: Food and Drug Administration (FDA) FDA Approves Truseltiq for Metastatic Cholangiocarcinoma FDA Approves Opdivo for Resected Esophageal Cancer FDA Approves Keytruda for HER2-Positive Stomach Cancer FDA Authorizes First Device that Uses Artificial Intelligence to Help Detect Colon Cancer Newsfeed Women Drinking More to Cope, Alarming Researchers Cancer Patients Still Face COVID-19 Pandemic-Related Health Care Delays World Blood Donor Day 2021: Give Blood and Keep the World Beating Discussing End-of-Life Care May Boost Hope for People With Advanced Cancer Blog: Food and Drug Administration (FDA) FDA Approves Truseltiq for Metastatic Cholangiocarcinoma FDA Approves Opdivo for Resected Esophageal Cancer FDA Approves Keytruda for HER2-Positive Stomach Cancer FDA Authorizes First Device that Uses Artificial Intelligence to Help Detect Colon Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: